Showing results (191-200 of 253) with videos related to

Sort By:
Pageof 26
Science Signaling|August 25, 2021
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo functionAlexander I Salter, Anusha Rajan, Jacob J Kennedy, et al.
Blood|January 15, 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigensEdus H Warren, Nobuharu Fujii, Yoshiki Akatsuka, et al.
Blood Advances|October 25, 2019
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapyMazyar Shadman, Jordan Gauthier, Kevin A Hay, et al.
Transplantation and Cellular Therapy|March 15, 2022
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple MyelomaSrirama Josyula, Margot J Pont, Sayan Dasgupta, et al.
Blood|April 15, 2017
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adultsRebecca A Gardner, Olivia Finney, Colleen Annesley, et al.
Journal for Immunotherapy of Cancer|February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicityTamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
EMBO Molecular Medicine|September 7, 2022
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activityGökhan Güner, Marlene Aßfalg, Kai Zhao, et al.
Blood|September 24, 2008
HapMap scanning of novel human minor histocompatibility antigensMichi Kamei, Yasuhito Nannya, Hiroki Torikai, et al.
Blood|February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Blood Advances|August 8, 2025
NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell LymphomaSairah Ahmed, John F DiPersio, James H Essell, et al.
Pageof 26